根據一篇尚未接受同行審查的文章(Ref1),Moderna及輝端疫苗兩者在人體所產生的抗體數量並無大分別,而且抗體所針對病毒的位置,亦跟自然感染武肺人士所產生的抗體相同。507Please respect copyright.PENANA2U4QQ0ZoBi
507Please respect copyright.PENANAMCU2Zl8pgL
注射兩者第二劑疫苗的3-14星期後,其抗體數量約與自然感染人士1.3個月後的數量接近。507Please respect copyright.PENANAsZIVJjcTwV
507Please respect copyright.PENANAwSWgrxkSmV
奈何的是,疫苗所產生的抗體,其應對英國/南非變種的能力明顯有所銳弱。根據抗體種類的不同,有一些抗體應對變種病毒的能力至少被銳弱了十倍以上有多。507Please respect copyright.PENANAs4aS7miMZq
507Please respect copyright.PENANAzPfzFwxJRc
同時間,把武肺病毒與疫苗抗體共同培植的話,能生存下來的武肺病毒亦出現與英國及南非變種一樣的排序,變相逆向證明疫苗或自然感染未變種病毒人士的抗體沒能有效應對最新的南非/英國或旗下牽伸的各種變種。507Please respect copyright.PENANAEc0lmWFNWd
507Please respect copyright.PENANAwQTdEzi4sg
若然屬實,Moderna/輝端疫苗很有可能要更新第二代作出應對。507Please respect copyright.PENANAXS1lHwXKal
507Please respect copyright.PENANA0lcg7IvzQQ
至於科興及國藥疫苗會否同屬一命運,則尚未清楚,但在理論層面上,滅活疫苗應對變種的可能性會較mRNA疫苗更高。507Please respect copyright.PENANAC2hSvLl6s6
507Please respect copyright.PENANA27GOZ5AZgJ
不過理論歸理論,一切尚需實驗證據確實。507Please respect copyright.PENANADe4rcWWK1n
507Please respect copyright.PENANAnVV9LYJajR
507Please respect copyright.PENANAxefYMtT53k
507Please respect copyright.PENANAE778GG4o3D
Ref1:https://www.biorxiv.org/content/10.1101/2021.01.15.426911v1.full.pdf507Please respect copyright.PENANAS2mhtU1Im1